4.4 Article

Pyrrolocarbazoles as checkpoint 1 kinase inhibitors

Journal

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
Volume 8, Issue 6, Pages 577-597

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187152008785133100

Keywords

checkpoint kinase 1; antitumor agents; pyrrolocarbazole; granulatimide

Ask authors/readers for more resources

The carbazole framework is found in many natural compounds of biological interest. Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites. In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy. This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compounds bearing four or five fused rings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available